Search results
Found 7361 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Professor Andrea Cipriani and the search for a revolution in mental health treatments - and an organ to play
6 February 2023
It may not be quite time to throw out the psychiatrist’s couch, but Oxford Professor of Psychiatry Andrea Cipriani is hoping his research might transform the traditional approach to mental health treatment.
Meet the ‘Fraud Guy’
6 February 2023
Dave Aylward recently joined the University as the Senior Counter Fraud Lead and Financial Manager and has already earned the nickname of the ‘Fraud Guy’! As part of the Financial Assurance and Counter Fraud team in the central Finance Division Dave looks at the University’s economic crime risk response. We had a quick chat with Dave to better understand his role and how we can help.
Communication at the crossroads of the immune system
6 February 2023
In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.
Showcase success for Science Together research
6 February 2023
A local collaboration teaming researchers from the University of Oxford and Oxford Brookes University with the Urban Music Foundation finished on a high note with an immersive sound and art installation at Oxford’s Old Fire Station.
Oxford spinout trials revolutionary bioelectronic implant to treat incontinence
1 February 2023
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.
COVID-19 is a leading cause of death in children and young people in the US
31 January 2023
A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.
Three or more concussions linked with worse brain function in later life
31 January 2023
Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.
New blood test could save lives of heart attack victims
31 January 2023
Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.
COVID-19 increased public trust in science, new survey shows
26 January 2023
A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.
New global health grant to improve outcomes for patients with hip fracture
26 January 2023
Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.
Gero Miesenböck awarded 2023 Japan Prize
24 January 2023
Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.
Major funding for Oxford will help find new cancer treatments
23 January 2023
Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology
23 January 2023
The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.
New study reveals role of lymphatic system in bone healing
19 January 2023
It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant
17 January 2023
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.
Oxford to lead international consortium to unlock potential of programmable nucleic acid drugs
17 January 2023
A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded £8m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.
Significant scale-up investment for three Oxford spinouts
16 January 2023
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Bodleian Update Jan 2023 - Journals and Databases
10 January 2023
Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people
3 January 2023
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.